BusinessAstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 BillionBy Riza DagocAug 3, 2026, 12:55 AM UTC
Insights & Views3 clinical-grade skincare creams you really shouldn’t buy onlineBy Lauren CortisJul 30, 2026, 7:38 AM UTC
BusinessGSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug PipelineBy Riza DagocJul 29, 2026, 4:11 AM UTC
BusinessAstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 OutlookBy Riza DagocJul 27, 2026, 9:02 AM UTC
HealthFDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to RiseBy Riza DagocJul 23, 2026, 1:23 AM UTC
PoliticsUS-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study FindsBy Riza DagocJul 22, 2026, 2:19 AM UTC
BusinessEli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health PipelineBy Riza DagocJul 16, 2026, 1:47 AM UTC
HealthTrump Administration Bars U.S. Travelers From Congo Flights Amid Ebola OutbreakBy Riza DagocJul 14, 2026, 3:55 AM UTC
